Catharanthine

CAS No. 2468-21-5

Catharanthine ( (+)-3,4-Didehydrocoronaridine )

Catalog No. M13718 CAS No. 2468-21-5

Catharanthine inhibits nicotinic receptor mediated diaphragm contractions with IC50 of 59.6 μM.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 35 In Stock
100MG 51 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Catharanthine
  • Note
    Research use only, not for human use.
  • Brief Description
    Catharanthine inhibits nicotinic receptor mediated diaphragm contractions with IC50 of 59.6 μM.
  • Description
    Catharanthine inhibits nicotinic receptor mediated diaphragm contractions with IC50 of 59.6 μM.
  • Synonyms
    (+)-3,4-Didehydrocoronaridine
  • Pathway
    Endocrinology/Hormones
  • Target
    AChR
  • Recptor
    nAChR
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    2468-21-5
  • Formula Weight
    336.42
  • Molecular Formula
    C21H24N2O2
  • Purity
    >98%(HPLC)
  • Solubility
    Ethanol: 3 mg/mL (8.91 mM); DMSO: 67 mg/mL (199.14 mM)
  • SMILES
    CCC1=C[C@H]2C[C@]3([C@@H]1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Pereira DM, et al. Phytomedicine, 2010, 17(8-9), 646-652.
molnova catalog
related products
  • SEN 12333

    α7 nicotinic acetylcholine receptor (nAChR) agonist.

  • Encenicline

    Encenicline is a selective α7 nicotinic acetylcholine receptor?(nAChRs) agonist in development for treating cognitive impairment in schizophrenia and Alzheimer's disease.

  • Catestatin

    Non-competitive nicotinic cholinergic antagonist; selectively inhibits nicotinic-stimulated catecholamine secretion from chromaffin cells and noradrenergic neurons (IC50 ~ 200 nM). Blocks nicotinic-induced cationic signaling (IC50 ~ 200 - 250 nM) and inhibits nicotinic-agonist induced desensitization of catecholamine release. Also stimulates mast cell release of histamine via a separate mechanism.